Prions can’t be killed by cooking, freezing, or standard disinfection, which makes prevention fundamentally different from preventing bacterial or viral infections. Instead, avoiding prion diseases comes down to reducing your exposure through food safety, medical safeguards, and, for some people, understanding genetic risk. Here’s what actually works.
Why Prions Are So Hard to Destroy
A prion is a misfolded protein that converts normal proteins in the brain into copies of itself, gradually destroying brain tissue. Unlike bacteria or viruses, prions have no DNA or RNA, so they can’t be targeted by antibiotics, antivirals, or your immune system. They resist boiling, UV light, standard autoclaving, and most chemical disinfectants. In soil, prions remain infectious for years, with one study detecting them after at least 29 months. This extraordinary durability is what makes prevention so important: once prions enter the body, there is currently no treatment that can stop the disease.
Food Safety and Meat Supply Protections
The most widely known prion exposure route is through contaminated meat. Variant CJD, the human form of mad cow disease, spread through beef products containing nervous system tissue from infected cattle. Since the 1990s outbreaks, countries have implemented feed bans (preventing cattle from eating animal-derived protein), removed high-risk tissues like brain and spinal cord from the food supply, and established surveillance testing of cattle herds. These measures have been effective. New cases of variant CJD have dropped to near zero globally.
For everyday consumers, there’s no special action required beyond what regulatory systems already provide. The beef, pork, and poultry you buy at a grocery store in the U.S., EU, Canada, or Australia has passed through these safeguards.
Precautions for Hunters
Chronic wasting disease (CWD) is a prion disease spreading through deer, elk, and moose populations in North America. No confirmed human cases have occurred, but the CDC recommends treating it as a real risk. If you hunt in areas where CWD has been detected, several practical steps reduce your exposure.
- Test before eating. Strongly consider having your deer or elk tested for CWD before consuming the meat. Check your state wildlife department for testing requirements or recommendations, as these vary by region.
- Avoid visibly sick animals. Do not shoot, handle, or eat animals that appear ill or behave abnormally, and never eat meat from animals found already dead.
- Protect yourself during field dressing. Wear latex or rubber gloves and avoid contact with the brain, spinal cord, and other internal organs. Use dedicated tools for field dressing rather than your kitchen knives.
- Request individual processing. If you take your animal to a commercial processor, ask that it be handled separately so your meat isn’t mixed with other carcasses.
- Never eat CWD-positive meat. If your animal’s test comes back positive, discard all meat from that animal.
How Hospitals Prevent Surgical Transmission
A small number of prion disease cases have been traced to contaminated surgical instruments, transplanted tissue, or medical products derived from human cadavers. This is called iatrogenic (medically caused) transmission. Because prions survive standard sterilization, hospitals follow specialized decontamination protocols for instruments that contact high-risk tissues like brain or spinal cord.
The CDC outlines three validated methods, all significantly more aggressive than routine sterilization. The most stringent involves soaking instruments in a strong sodium hydroxide solution, then heating them in an autoclave at 121°C (250°F) for 30 minutes, followed by a second round of standard sterilization. Alternative methods use sodium hypochlorite (concentrated bleach) with one-hour soaking times combined with extended autoclave cycles. Surfaces and heat-sensitive equipment that can’t withstand autoclaving are flooded with concentrated sodium hydroxide or undiluted bleach for at least one hour.
For patients, the practical takeaway is that modern hospitals in developed countries follow these protocols as standard practice when operating on neurological tissue. Single-use disposable instruments are increasingly used for high-risk procedures, eliminating the reuse problem entirely.
Blood and Tissue Donation Safeguards
There is no blood test that can detect prions in a living person before symptoms appear, so the blood supply relies on donor screening rather than direct testing. The FDA recommends permanent deferral for anyone diagnosed with CJD or any prion disease, anyone with a blood relative diagnosed with a hereditary form of prion disease, and anyone who received a cadaveric dura mater transplant or cadaveric pituitary growth hormone treatment. These last two categories reflect historical medical practices that caused small clusters of iatrogenic CJD.
Previously, donors were also deferred for spending time in the United Kingdom or other European countries during the mad cow disease era. The FDA has since lifted those geographic deferrals, allowing previously excluded donors to give blood as long as they meet all other eligibility requirements. However, people with a family history of genetic prion disease or a history of cadaveric growth hormone treatment remain permanently ineligible.
Genetic Risk and Testing
About 10 to 15 percent of human prion disease cases are hereditary, caused by mutations in the PRNP gene. These include fatal familial insomnia, Gerstmann-Sträussler-Scheinker syndrome, and familial CJD. Each child of an affected parent has a 50 percent chance of inheriting the mutation.
Genetic testing for PRNP mutations is available and can identify whether an at-risk person carries a pathogenic variant. Guidelines from genetics societies recommend that anyone with a known or suspected family history of prion disease consult a clinical genetics service. Predictive testing (testing a healthy person to determine future risk) is an option, though it carries significant psychological weight since no preventive treatment currently exists. Pre-implantation genetic testing is also available for couples who carry a PRNP mutation and want to ensure the mutation is not passed to their children.
If a family member has been diagnosed with any form of prion disease and the genetic basis is unknown, diagnostic PRNP testing of the affected person can clarify whether other relatives are potentially at risk. A negative result in the affected person generally means the disease is sporadic rather than inherited, which removes the concern for blood relatives.
What Science Is Working Toward
No drug or vaccine can currently prevent prion diseases in humans, but research is targeting several points in the process. One approach focuses on stabilizing the normal prion protein so it resists being converted into its misfolded form. Another aims to reduce the amount of normal prion protein the body produces in the first place, since less raw material means fewer opportunities for misfolding. Researchers have also explored disrupting the specific cellular locations where conversion happens, particularly cholesterol-rich areas on cell membranes called lipid rafts. Depleting cholesterol from these sites appears to slow the misfolding process in laboratory settings.
Antibody-based therapies that bind to either the normal or misfolded prion protein are also under investigation, along with enzymes capable of breaking down misfolded prions. One engineered enzyme achieved a greater than ten-million-fold reduction in prion infectivity under laboratory conditions, though translating that to a human therapy remains a distant goal. For now, prevention depends entirely on the exposure-reduction strategies outlined above.